Skip to main content

    Roundup of Pharmapalooza Workshop Session

    AAPOS 2023
    Pediatric Ophth/Strabismus

    Drs. Laura Enyedi and Maria Lim discuss the "Pharmapalooza" workshop held at the 2023 AAPOS meeting, which covered new drugs of interest to pediatric ophthalmologists. Some of these agents include dupilumab for atopic dermatitis, which can cause ocular surface disease and atopic keratoconjunctivitis; ivacaftor for cystic fibrosis, which can cause cataracts; and bevacizumab for retinopathy of prematurity.

    Financial Disclosures: Dr. Laura Enyedi discloses financial relationships with Cooper Vision, Novartis (Consultant/Advisor); Ocular Therapeutix (Grant Support); Sophia Pharma (Lecture Fees/Speakers Bureau); Wolters Kluwer Health (Patents/Royalty). Dr. Maria Lim discloses no financial relationships.